Astria Therapeutics, Inc. ATXS
12.58 USD 0.00 (+0.00%)
At closeJan 23, 2026, 4:00 PM EST
12.58 0.00 0.00%
After hours · Jan 23, 4:00 PM ET
12.58 Day range 12.58
52-week range unavailable
- YTD
- -3.90%
- 1 year
- +66.62%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 26.43 +110.1% upside
Now 12.58
- Target (low)
- 16.00
- Target (mean)
- 26.43
- Target (high)
- 35.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -1.95 | -1.95 – -1.95 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | -1.85 | -1.85 – -1.85 | -1.95 | +5.1% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 13, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 29, 2024 | TD Cowen | Initiated | — | Buy |
| May 21, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| May 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Apr 23, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 26, 2024 | Wedbush | Maintained | Outperform | Outperform |
| Mar 26, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 25, 2024 | Jefferies | Maintained | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 5, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 30, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 15, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 13, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Oct 12, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 8, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Aug 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 8, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 12, 2023 | Wedbush | Reiterated | — | Outperform |
| May 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 28, 2023 | Evercore ISI Group | Initiated | — | Outperform |